# Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus

> **NCT06281899** · PHASE4 · UNKNOWN · sponsor: **Anemia Working Group Romania** · enrollment: 200 (estimated)

## Conditions studied

- Chronic Kidney Diseases
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Dapagliflozin 10 mg Tab
- **BEHAVIORAL:** Low protein diet

## Key facts

- **NCT ID:** NCT06281899
- **Lead sponsor:** Anemia Working Group Romania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06281899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06281899, "Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06281899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*